| Oct 2 |
Allurion started at buy by Jefferies ahead of data for obesity therapy
|
| Oct 1 |
Allurion Announces Publication of Meta-Analysis Demonstrating the Safety and Effectiveness of the Allurion Program for Weight Loss
|
| Sep 6 |
Allurion started at buy by Roth MKM over weight-loss device potential
|
| Sep 5 |
Allurion receives non-compliance notice from NYSE
|
| Sep 5 |
Allurion Announces Publication of New Data Demonstrating Weight Loss in Adolescents Suffering from Obesity
|
| Sep 3 |
Allurion Announces the Appointment of Eli Lilly Veteran, Keith Johns, to Its Board of Directors
|
| Aug 28 |
Allurion Announces Publication of New Data Demonstrating Continued Weight Loss at One Year On the Allurion Program
|
| Aug 20 |
Allurion Announces the Appointment of Adrian Wild as Senior Vice President, International Commercial
|
| Aug 15 |
Allurion receives continued listing standards notice from NYSE
|
| Aug 15 |
Allurion Receives Continued Listing Standards Notice from NYSE
|
